Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients

Launched by TANTA UNIVERSITY · Sep 17, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help patients with difficult airways during intubation, which is a procedure where a tube is placed in the airway to help with breathing. The study compares two methods: using sevoflurane sedation, a type of medication that helps patients relax and feel comfortable, versus using local anesthesia in the throat. The goal is to see which method provides better satisfaction for patients and easier intubation conditions.

To participate in this trial, patients need to be between 18 and 50 years old, of any gender, and have specific challenges with their airways, like certain physical characteristics that make intubation difficult. However, people with certain health issues, allergies to the medications, or a history of drug abuse won't be eligible. If you join the study, you can expect to receive either sedation or throat numbing before the intubation process, and your experience will be carefully monitored to determine which method works best.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age from 18 to 50 years.
• • Both sexes.
• • American Society of Anesthesiology (ASA) physical status I-II.
• • Patients with difficult airway (Mallampati grade 3 and 4 with mouth opening less than 5 cm).
• Exclusion Criteria:
• • Patient refusal.
• • Patients with bleeding disorders and nasal mass.
• • Allergy or intolerance to one of the study medications.
• • Patients with uncontrolled systemic diseases.
• • patients with gastro-esophageal reflex.
• • history of nasopharyngeal surgery or drug abuse.